ABP News on MSN
Bengaluru man arrested for murder of woman software engineer
Bengaluru: Bengaluru police on Sunday said they have arrested a 18-year-old man on murder charges in connection with the ...
SC Hearing Sonam Wangchuk Detention Case Today News Highlights Updates: The climate activist was detained on September 26, ...
CARDINAL Phase 1/2 trial of TERN-701 enrolling well, with multiple important milestones in 2026Planned milestones include pivotal dose selection, ...
Gitanjali Angmo also acknowledged the ‘tremendous goodwill the people have for Sonam and for our institute and for us... the ...
ORLANDO, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced its plans ...
Skims, the apparel brand co-founded by Kim Kardashian, made its first venture into live entertainment with “Kimsmas Live!,” a 45-minute holiday livestream event that was broadcast exclusively on ...
Energy and marine consultancy ABL has secured new five-year contracts with long-term client Woodside Energy that expands its existing workscope outside of Australia. ABL has been awarded a global ...
LAUNCH COMPLEX 14, Cape Canaveral, Fla.—The platform atop the hulking steel tower offered a sweeping view of Florida’s rich, sandy coastline and brilliant blue waves beyond. Yet as captivating as the ...
South Korea’s newest billionaire is Lee Sang-hoon, founder of Seoul-based ABL Bio, after it struck a $2.6 billion licensing and joint research deal with Eli Lilly for its bispecific antibody ...
The companies have yet to disclose how many programs they plan to collaborate on or what indications they will prioritize. For the second time in as many weeks, Eli Lilly is taking out its checkbook ...
ABL Bio Inc. inked a license and research agreement with Eli Lilly and Co. worth up to $2.6 billion to develop multiple therapeutics using the Grabody-B platform. Under the terms announced Nov. 12, ...
Neok Bio has exited stealth with $75 million to take a pair of bispecific antibody-drug conjugates sourced from ABL Bio into the clinic. ABL, a Korean biotech that is partnered with companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results